Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2007 by Lymphoma Study Association.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Janssen-Cilag International NV
Information provided by:
Lymphoma Study Association
ClinicalTrials.gov Identifier:
NCT00136565
First received: August 26, 2005
Last updated: November 6, 2007
Last verified: November 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2008
  Estimated Primary Completion Date: No date given